Surrozen Announces Safety, Pharmacodynamic and Liver
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043...
Source: globenewswire.com
📰 Initiating Phase News
Initiating Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Initiating Phase. Real-time updates on events, politics, business and more.
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
Phase 1a trial demonstrated acceptable safety and tolerability with no reported serious adverse events -Phase 1a data demonstrated target engagement, a…
Source: biztoc.com
Bavarian Nordic to Raise $250 Million for RSV Vaccine Phase 3 Trial
(PLX AI) - Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital Base.• Says total estimated cost of the study is approximately USD 250 million,
Source: finanznachrichten.de